We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYXTW
1001
CALL
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
$1.73M 0.01%
+166,661
New +$279K
URBN icon
1002
Urban Outfitters
URBN
$6.22B
$1.72M 0.01%
+67,364
New +$1.74M
AVB icon
1003
AvalonBay Communities
AVB
$26.8B
$1.72M 0.01%
10,726
-17,598
-62% -$2.8M
SEI
1004
Solaris Energy Infrastructure
SEI
$3.22B
$1.72M 0.01%
210,893
-95,970
-31% -$685K
FAII.WS
1005
CALL
DELISTED
Fortress Value Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class
FAII.WS
$1.72M 0.01%
+159,997
New +$269K
ORGO icon
1006
Organogenesis Holdings
ORGO
$328M
$1.72M 0.01%
+228,025
New +$1.08M
H icon
1007
Hyatt Hotels
H
$18B
$1.71M 0.01%
+23,013
New +$1.5M
ROP icon
1008
Roper Technologies
ROP
$37.1B
$1.71M 0.01%
+3,955
New +$1.62M
JKHY icon
1009
Jack Henry & Associates
JKHY
$10.9B
$1.7M 0.01%
10,499
+5,129
+96% +$814K
BLMN icon
1010
Bloomin' Brands
BLMN
$731M
$1.7M 0.01%
87,543
-33,840
-28% -$577K
PHM icon
1011
Pultegroup
PHM
$24.9B
$1.7M 0.01%
+39,366
New +$1.74M
SLP icon
1012
Simulations Plus
SLP
$371M
$1.7M 0.01%
+23,575
New +$1.56M
TIMB icon
1013
TIM SA
TIMB
$9.98B
$1.69M 0.01%
+121,452
New +$1.52M
AMRS
1014
DELISTED
Amyris Inc.
AMRS
$1.68M 0.01%
+272,597
New +$872K
DD icon
1015
DuPont de Nemours
DD
$18.9B
$1.68M 0.01%
18,836
-13,610
-42% -$1.07M
STWOW
1016
CALL
DELISTED
ACON S2 Acquisition Corp Warrant
STWOW
$1.68M 0.01%
+166,663
New +$217K
JWN
1017
DELISTED
Nordstrom
JWN
$1.68M 0.01%
53,711
-48,732
-48% -$1.02M
NARI
1018
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.67M 0.01%
+19,150
New +$1.35M
NVRO
1019
DELISTED
NEVRO CORP.
NVRO
$1.67M 0.01%
+9,630
New +$1.56M
OMCL icon
1020
Omnicell
OMCL
$1.89B
$1.66M 0.01%
13,861
-12,359
-47% -$1.21M
AMK
1021
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$1.66M 0.01%
+68,710
New +$1.63M
EEFT icon
1022
Euronet Worldwide
EEFT
$3.01B
$1.66M 0.01%
+11,437
New +$1.33M
ALG icon
1023
Alamo Group
ALG
$2B
$1.64M 0.01%
11,903
-19,271
-62% -$2.5M
CNST
1024
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.64M 0.01%
+56,991
New +$1.43M
DCI icon
1025
Donaldson
DCI
$10.8B
$1.64M 0.01%
29,357
-274,814
-90% -$14.5M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.